J
Jyothish Soman
Researcher at IBM
Publications - 21
Citations - 275
Jyothish Soman is an academic researcher from IBM. The author has contributed to research in topics: Graph (abstract data type) & Computer science. The author has an hindex of 8, co-authored 19 publications receiving 247 citations. Previous affiliations of Jyothish Soman include University of Cambridge & International Institute of Information Technology, Hyderabad.
Papers
More filters
Proceedings ArticleDOI
A fast GPU algorithm for graph connectivity
TL;DR: This work presents a GPU-optimized implementation for finding the connected components of a given graph, and tries to minimize the impact of irregularity, both at the data level and functional level.
Proceedings ArticleDOI
Fast Community Detection Algorithm with GPUs and Multicore Architectures
Jyothish Soman,Ankur Narang +1 more
TL;DR: The design of a novel scalable parallel algorithm for community detection optimized for multi-core and GPU architectures based on label propagation, which works solely on local information, thus giving it the scalability advantage over conventional approaches is presented.
Journal ArticleDOI
Some gpu algorithms for graph connected components and spanning tree
TL;DR: This paper presents results that show how to use GPUs efficiently for graph algorithms which are known to have irregular data access patterns, and arrives at efficient GPU implementations for the above two problems.
Patent
Distributed Data Scalable Adaptive Map-Reduce Framework
Ankur Narang,Jyothish Soman +1 more
TL;DR: In this article, a distributed data scalable adaptive map-reduce framework for at least one multi-core cluster is presented, which includes partitioning a cluster into at least 1 computational group, determining at least 3 key-group leaders within each computational group and performing a local combine operation at each group.
Posted Content
Utilising Graph Machine Learning within Drug Discovery and Development
Thomas Gaudelet,Ben Day,Arian R. Jamasb,Jyothish Soman,Cristian Regep,Gertrude Liu,Jeremy B. R. Hayter,Richard Vickers,Charles Roberts,Jian Tang,David Roblin,Tom L. Blundell,Michael M. Bronstein,Jake P. Taylor-King +13 more
TL;DR: A chronologically through the drug development pipeline, key milestones including repurposed drugs entering in vivo studies, suggest graph machine learning will become a modelling framework of choice within biomedical machine learning.